Nanose Medical
Nanose Medical is a pioneering company dedicated to early disease detection through innovative non-invasive diagnostics. Utilizing breakthrough AI-driven sensing technology, they focus on breath biomarkers to enable rapid, affordable, and highly accurate screening for conditions such as lung cancer, liver diseases, and chronic liver conditions like MASLD and MASH. Their mission is to improve healthcare accessibility and outcomes by providing early detection tools that facilitate timely intervention and treatment.
Industries
Nr. of Employees
small (1-50)
Products
Portable breath-based diagnostic device
A portable handheld device that analyzes exhaled breath VOCs and provides rapid diagnostic outputs intended for point-of-care screening and longitudinal monitoring.
Portable breath-based diagnostic device
A portable handheld device that analyzes exhaled breath VOCs and provides rapid diagnostic outputs intended for point-of-care screening and longitudinal monitoring.
Services
Collaborative execution of clinical validation studies and participation in multi-center research consortia focused on early detection and management using breath-based diagnostics.
Integration and deployment of breath-sensing into remote patient monitoring workflows to support longitudinal management and early intervention.
Services supporting device prototyping, technology-transfer readiness, regulatory planning and commercialization strategy for diagnostic devices and sensor platforms.
Leadership and participation in grant-funded innovation projects, including management of EU-funded multi-partner consortia and delivery of translational research work packages.
Support for preparation and dissemination of peer-reviewed manuscripts, abstracts and conference materials reporting sensor development and clinical validation outcomes.
Collaborative execution of clinical validation studies and participation in multi-center research consortia focused on early detection and management using breath-based diagnostics.
Integration and deployment of breath-sensing into remote patient monitoring workflows to support longitudinal management and early intervention.
Services supporting device prototyping, technology-transfer readiness, regulatory planning and commercialization strategy for diagnostic devices and sensor platforms.
Leadership and participation in grant-funded innovation projects, including management of EU-funded multi-partner consortia and delivery of translational research work packages.
Support for preparation and dissemination of peer-reviewed manuscripts, abstracts and conference materials reporting sensor development and clinical validation outcomes.
Expertise Areas
- Breath-based diagnostics and volatolomics
- Clinical validation and diagnostic performance studies
- Machine learning and data analytics for diagnostic sensors
- Nanomaterials-based sensor research and development
Key Technologies
- Nanoscale sensor materials
- Sensor array (electronic nose) for multiplex VOC detection
- Volatile organic compound (VOC) analysis
- Machine learning classification and pattern recognition
News & Updates
A poster published at the EASL SLD Summit 2025, discussing a rapid breath test for early detection of liver disease.
Research on nanoscale sensor technologies for disease detection through analysis of exhaled molecules.
Study on diagnosing multiple diseases from breath analysis using pattern analysis of exhaled molecules.
A poster published at the EASL SLD Summit 2025, discussing a rapid breath test for early detection of liver disease.
Research on nanoscale sensor technologies for disease detection through analysis of exhaled molecules.
Study on diagnosing multiple diseases from breath analysis using pattern analysis of exhaled molecules.